Tuberculosis Diagnostics Market Size

Market Outlook:

Tuberculosis Diagnostics Market size is anticipated to grow significantly, reaching USD 4.12 billion by 2034, up from USD 2.32 billion. This growth represents a CAGR of over 5.9%, with a revenue forecast of USD 2.44 billion for 2025.

• Base Year Value (2024): USD 2.32 billion
• CAGR (2025-2034): 5.9%
• Forecast Year Value (2034): USD 4.12 billion
• Historical Data Period: 2019-2024
• Largest Region: Asia Pacific
• Forecast Period: 2025-2034

Market Dynamics:

Growth Drivers & Opportunity: Increasing prevalence of tuberculosis worldwide is driving the growth of the tuberculosis diagnostics market. Rising awareness about early diagnosis and treatment of the disease is also contributing to market growth. Additionally, advancements in diagnostic technologies such as molecular diagnostic tests are further fueling market expansion. Industry

Report Scope

Report Coverage	Details
Segments Covered	Test Type, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, BioMérieux SA, Hain Lifescience, QIAGEN, Cepheid, Hologic, BD

Limited access to diagnostic facilities in developing regions remains a major restraint for the tuberculosis diagnostics market. High cost of diagnostic tests and lack of skilled healthcare professionals for accurate diagnosis are also hindering market growth.